Our colleague Kevin Boos is looking forward to connecting with you. The COG West Coast brings senior decision-makers from across the Bay Area
Our colleagues Luan Nguyen and Victor Iorgulescu are looking forward to connecting with the many Life Science thought-leaders
Our colleagues are looking forward to connecting with the many professionals gathered around the same purpose: improving outcomes for cancer patients.
At the bottom of the EBM hierarchy, mechanistic evidence is not highly valued by the HTA bodies responsible for evaluating therapies, either for drawing up…
Lionel RIOU FRANÇA, Chief Scientific Officer, was involved in two analyses involving patients with Late-Onset Pompe Disease…
Cell and gene therapies are multiplying, and with them the hopes of patients, their families, and healthcare professionals…
Cmed and Larix fully integrate into Aixial Group Press release – May 30th 2023 Following its acquisition of Larix in…
Rare Diseases: Phase I First-in-Human Study on Wilson’s Disease Case study This case study looks at the challenges that arose…
Cell & Gene Therapy: Safety and Clinical Activity in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma Case…
Rare Diseases: Phase II Pediatric Study with Selected Metabolic Disorders Case study Aixial Group is currently working on a Phase…
Data Science & Analytics: Combining A Phase I Study with an On-Going Observational Study Case study This case study looks…
Early Phase Oncology: First-In-Human Study Of An Antibody-Drug Conjugate In Breast Cancer Case study For a First In Human study,…
